{"id":71902,"date":"2013-02-06T16:51:24","date_gmt":"2013-02-06T21:51:24","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/modernizing-medicine-is-named-one-of-americas-most-promising-companies-by-forbes.php"},"modified":"2013-02-06T16:51:24","modified_gmt":"2013-02-06T21:51:24","slug":"modernizing-medicine-is-named-one-of-americas-most-promising-companies-by-forbes","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/modernizing-medicine-is-named-one-of-americas-most-promising-companies-by-forbes.php","title":{"rendered":"Modernizing Medicine Is Named One of &#39;America&#39;s Most Promising Companies&#39; by FORBES"},"content":{"rendered":"<p><p>    BOCA RATON, FL--(Marketwire - Feb 6, 2013) -    Modernizing    Medicine, the creator of the Electronic Medical Assistant    (EMA), a cloud-based specialty-specific electronic medical    records (EMR) application, announced today that it has been    listed at No. 47 on FORBES' annual ranking of America's Most    Promising Companies -- a list of one hundred privately held,    high-growth companies with bright futures.  <\/p>\n<p>    \"We are honored to be recognized alongside so many innovators    as one of America's Most Promising Companies,\" said Daniel    Cane, Modernizing Medicine's President and CEO. \"This has been    an incredible year of growth for Modernizing Medicine and to    receive this award from one of the world's leading business    publications is confirmation that our transformative technology    is making its mark on the healthcare industry.\"  <\/p>\n<p>    FORBES' list of 'America's Most Promising Companies' features    100 privately held up-and-comers that are poised to grow and    change the world with their compelling business models, strong    management teams, notable customers, strategic partners and    dynamic investors.  <\/p>\n<p>    For the Most Promising list, FORBES strove for a holistic gauge    of young, privately-held companies, trying to pin down their    trajectories by looking at a slew of variables. Over the course    of six months FORBES reviewed thousands of applications. The    final assessment is based on growth (both in sales and hiring),    quality of management team and investors, margins, market size    and key partnerships. FORBES turned to CB Insights, a    Manhattan-based data research firm that specializes in    assessing private companies, to refine the search. Their MOSAIC    software scans 45,000 sources to measure a company's health. A    new distribution deal, for example, marks a positive signal,    while the loss of an executive is a negative. MOSAIC gathers    those myriad signals into a final score that FORBES uses as an    initial guide in producing the list. After verifying sales    numbers, speaking with each company and debating their merits    and blemishes, FORBES produces a final ranking.  <\/p>\n<p>    Modernizing Medicine's inclusion on FORBES' list comes at the    close of an incredible year for the three-year old company. In    2012, Modernizing Medicine grew its customer base by over    1000%, bringing the total number of providers using EMA to over    2,000. Modernizing Medicine also more than doubled its staff,    grew its product line with the addition of     EMA Plastic Surgery and closed a $12 million dollar    capital raise, with a combination of equity capital and a    senior debt bank facility. The company was named the #1 Fastest    Growing Company in South Florida by the South Florida Business    Journal in its \"Fast 50,\" the #1 \"Top Mobile Startup in South    Florida\" by the South Florida Technology Alliance and was named    one of the \"2012 Florida Companies to Watch\" by the Florida    Economic Gardening Institute. Daniel Cane was also recognized    as a great leader and innovator with '40 Under 40' awards from    the South Florida Business Journal and Enterprise Florida, Inc.  <\/p>\n<p>    Modernizing Medicine is looking forward to an exciting year,    with the launch of     EMA Cosmetic,     EMA Orthopedics and EMA Otolaryngology.  <\/p>\n<p>    About Modernizing MedicineModernizing    Medicine is delivering the next generation of electronic    medical records (EMR) technology for the healthcare industry.    Our product, Electronic Medical Assistant (EMA), is a    cloud-based specialty-specific EMR with a massive library of    built-in medical content, designed to save physicians time.    Available as a native iPad application or from any web-enabled    Mac or PC, EMA adapts to each provider's unique style of    practice and is designed to interface with over 400 different    practice management systems. Today, Modernizing Medicine    provides specialty-specific offerings for the dermatology,    ophthalmology, optometry and plastic surgery markets, and to    more than 750 physician practices across the country.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read this article:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/modernizing-medicine-named-one-americas-152227463.html;_ylt=A2KJjbxP0BJRNjwAKI__wgt.\" title=\"Modernizing Medicine Is Named One of &#39;America&#39;s Most Promising Companies&#39; by FORBES\">Modernizing Medicine Is Named One of &#39;America&#39;s Most Promising Companies&#39; by FORBES<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> BOCA RATON, FL--(Marketwire - Feb 6, 2013) - Modernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based specialty-specific electronic medical records (EMR) application, announced today that it has been listed at No.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/modernizing-medicine-is-named-one-of-americas-most-promising-companies-by-forbes.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-71902","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/71902"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=71902"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/71902\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=71902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=71902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=71902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}